3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
78
Precursor Cell Lymphoblastic Leukemia-Lymphoma
65
Myelodysplastic Syndromes
59
Leukemia, Lymphocytic, Chronic, B-Cell
56
Lymphoma, Non-Hodgkin
55
Multiple Myeloma
52
Hodgkin Disease
52
Leukemia
48
Lymphoma, Mantle-Cell
43
Lymphoma
39
Lymphoma, Follicular
38
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
38
Myeloproliferative Disorders
36
Lymphoma, B-Cell, Marginal Zone
36
Lymphoma, Large B-Cell, Diffuse
35
Burkitt Lymphoma
34
Leukemia, Myelomonocytic, Chronic
30
Congenital Abnormalities
30
Lymphoma, Large-Cell, Immunoblastic
27
Waldenstrom Macroglobulinemia
26
Leukemia, Myeloid, Accelerated Phase
25
Leukemia, Myeloid, Chronic-Phase
23
Hematologic Neoplasms
22
Blast Crisis
22
Primary Myelofibrosis
21
Anemia, Refractory, with Excess of Blasts
21
Dendritic Cell Sarcoma, Interdigitating
20
Lymphoma, T-Cell, Cutaneous
18
Lymphoma, Large-Cell, Anaplastic
18
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Interventions
blinatumomab
4
Rituximab
4
Cyclophosphamide
3
ponatinib
2
Vorinostat
2
Vincristine
2
Prednisone
2
Ifosfamide
2
Etoposide
2
Doxorubicin
2
Brentuximab Vedotin
2
Bortezomib
2
tetulomab tetraxetan lu-177
1
pembrolizumab
1
pegaspargase
1
ibrutinib
1
ibritumomab tiuxetan
1
durvalumab
1
cobomarsen
1
asparaginase erwinia chrysanthemi recombinant
1
acalabrutinib
1
Methotrexate
1
Melphalan
1
Lutetium
1
Lenalidomide
1
KW-2478
1
Imatinib Mesylate
1
Hsp90 inhibitor KU757
1
Dexamethasone
1
Daunorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoproliferative Disorders
×
Whole-Body Irradiation
×
Clear all
No trials found.